Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
Lung Cancer (Amsterdam, Netherlands)|September 11, 2020
Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasmsM Rubino, J Y Scoazec, E Pisa, et al.
Scientific Reports|October 10, 2020
Exploitation of the chick embryo chorioallantoic membrane (CAM) as a platform for anti-metastatic drug testingP Pawlikowska, T Tayoun, M Oulhen, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 21, 2021
[Artificial intelligence, radiomics and pathomics to predict response and survival of patients treated with radiations]R Sun, M Lerousseau, T Henry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2021
ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical researchC Belli, F Penault-Llorca, M Ladanyi, et al.
Endocrine-Related Cancer|March 15, 2015
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinomaJ Hadoux, D Malka, D Planchard, et al.
Virchows Archiv : an International Journal of Pathology|September 13, 2006
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading systemG Rindi, G Klöppel, H Alhman, et al.
Oncogene|June 7, 2011
TP63 P2 promoter functional analysis identifies β-catenin as a key regulator of ΔNp63 expressionC Ruptier, A De Gaspéris, S Ansieau, et al.
British Journal of Cancer|May 14, 2009
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonismB Cambien, B F Karimdjee, P Richard-Fiardo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2017
Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohortT Walter, D Tougeron, E Baudin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2022
Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patientsJ Chen, F Facchinetti, F Braye, et al.
Pageof 17